12/10/2024 | Press release | Distributed by Public on 12/11/2024 05:01
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Qualification | |
Date Qualified: | December 10, 2024 9:30 A.M. |
Form: | 1-A |
CIK: | 0001589150 |
Company Name: | Regen BioPharma Inc |
File Number: | 024-12505 |